PHACE - Prospective Genetic Investigation
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT05133245
- Status
- Enrolling By Invitation
Conditions
- PHACE Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Diagnostic study only — OTHERDiagnostic study only
Study Details
Investigation for potential PHACE syndrome gene.
Key Dates
- Start date
- Nov 1, 2021
- Status verified
- Dec 2025
- Primary completion
- Nov 1, 2026
- Completion
- Nov 1, 2026
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
Potential PHACE Gene Identification [ Time Frame: 3 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt Eye Institute | Nashville | Tennessee | 37232 | - |
Find similar trials in Nashville, TN
By research site